The Zika virus can make people feel unwell and have difficulty swallowing, but there’s no vaccine or treatment for it.
As a result, the vast majority of people in the Americas who have had Zika in the past will continue to have it.
But some doctors have begun prescribing anti-Zika medications, and it is now possible to take them in the UK and Australia, which have the highest rates of Zika infection.
There are a number of drugs, some of which have already been approved in the US, that have been developed to treat Zika in a lab, to reduce the chances of transmitting the virus.
The most widely used is Truvada, a highly effective anti-HIV drug.
The British drug manufacturer GlaxoSmithKline is also developing its own anti-infective drug, which can be given in a pill or injected.
One of the biggest problems is that it can take weeks for people to recover from a Zika infection, and even then it can be very difficult to get better.
As a result of this, doctors are turning to medication that is currently available in the market.
“The main problem is that we have a limited supply of anti-disease drugs in the United States,” Dr. Anthony Fauci, the chief of infectious disease at Imperial College London, told Al Jazeera.
“It’s a really difficult situation.”
It’s not clear why this is the case, and Dr. Faucso explained that the US government has been slow to approve drugs.
In Europe, there is currently no regulatory framework for drug approvals and a lack of awareness about Zika infections.
The UK government, which has been a leading donor to research into Zika, is still waiting on approval of a Zika vaccine, which could take five years.
However, the government’s new strategy to address the virus will include a trial of Truvadex, which was approved in March.
This drug is being developed by Bristol-Myers Squibb, which makes an anti-viral called Truvion.
Truvadea is a combination of a drug called Trizolab, which blocks the immune system’s ability to fight off infection, with a synthetic version of a protein known as CCR5.
In a vaccine, it blocks the protein from getting into the blood stream, and also blocks the antibodies that protect the body from infection.
The researchers are hoping to see the vaccine approved in 2018, and are hoping it will reduce the virus’ impact on the body.
Dr. Anthony D. Fai, director of the Institute of Infectious Diseases at Imperial, said that people are likely to get a “good response” to the medication.
“The drug is a relatively safe drug, and so the side effects are very minor,” he said.
“The side effects tend to be mild.
Truviadis and other anti-bodies to treat the virus Antibodies are antibodies that are produced by the immune systems to fight infection. “
People will not get very ill, but if you do, the side-effects are severe.”
Truviadis and other anti-bodies to treat the virus Antibodies are antibodies that are produced by the immune systems to fight infection.
They can protect against viruses by binding to them and killing them, or by blocking the immune response.
But when it comes to Zika, the drugs don’t work very well against the virus, so it’s very important to get these drugs into the right hands.
It is not yet known if Truvaxa or another drug will work better, and if they will.
Both Truvazapine and Truvudan have been approved by the US Food and Drug Administration (FDA) and will be used to treat people with Zika who have not yet recovered from a mild infection.
These drugs are not approved for use in pregnant women.
However, a British study published in the Lancet Infectious Disease journal found that Truvadans were effective in treating patients who had recovered from mild Zika infections and also treated some who had had Zika after a mild viral infection.
Treatment of the virus in the first weeks of the pandemic There are two treatments that can be used, which are called “pandemic anti-inflammatory” drugs and “panda anti-rabbit.”
Pandemic anti inflammatory drugs are drugs that target a particular type of virus in an immune system.
They are injected into the bloodstream and are thought to be able to fight the virus more effectively than standard treatments.
Panda anti rabbit is a drug that works on the immune cells in the brain, and the antibodies it produces work better against the antibodies of the Zika virus than against normal antibodies.
However it does not seem to have as good a chance of stopping the virus from infecting people.
For people who have the vaccine, they will need to take a medication called ZMapp, which is also available in Europe.